Cyclooxygenase 1 and 2 in rheumatic disease: Implications fornonsteroidal anti-inflammatory drug therapy
Author:
- 1 August 1996
- journal article
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 26 (1) , 435-446
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Proinflammatory Cytokines Regulate Cyclooxygenase-2 mRNA Expression in Human MacrophagesBiochemical and Biophysical Research Communications, 1995
- Nonsteroidal antiinflammatory drugs and the gastrointestinal tract the double-edged swordArthritis & Rheumatism, 1995
- Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus systemBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1994
- Expression of mRNA for cyclooxygenase‐1 and cyclooxygenase‐2 in human tissuesFEBS Letters, 1993
- Prostaglandin endoperoxide synthase: regulation of enzyme expressionBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991
- Tenidap, in contrast to several available nonsteroidal antiinflammatory drugs, potently inhibits the release of activated neutrophil collagenaseArthritis & Rheumatism, 1991
- Effect on gastric and duodenal mucosal prostaglandins of repeated intake of therapeutic doses of naproxen and etodolac in rheumatoid arthritis.Annals of the Rheumatic Diseases, 1990
- Effects of Non-Narcotic Analgesics on the KidneyDrugs, 1986
- Effect of nabumetone (BRL 14777), a new anti-inflammatory drug, on human platelet reactivity ex vivo: comparison with naproxenJournal of Pharmacy and Pharmacology, 1982
- Ethanol Potentiation of Aspirin-Induced Prolongation of the Bleeding TimeNew England Journal of Medicine, 1982